Risk-Profile-for-Amyotrophic-Lateral-Sclerosis-(ALS) An-Approach-with-the-Study-on-Cytokine-Polymorphisms

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder where neuroinflammation plays an important role; previous data suggest that cytokines are strongly involved. A group of ALS patients were studied for immune protein polymorphisms: a case-control study to determine statistically significant differences in allelic, genotypic and haplotypic frequencies of 22 genetic polymorphisms of 13 cytokines was performed. The aim was the detection of a risk profile for the potential identification of individuals prone to disease and the discovery of possible targets for medication or lifestyle modification. From statistical analysis a significant difference was observed in polymorphisms of IL-1β +3962 (genotype: CC p = 0.0347; CT p = 0.0149), TGF-β codon 25 (genotype: CG p = 0.0126; GG p = 0.013) and TNF-α -238 (genotype: AA p = 0.019). We take into consideration all possible haplotypes, observing a significance of TG haplotype in two IL-2 gene polymorphisms (-330,+166; p =0.0038), and CC haplotype of TGF-β (codon 10, codon 25; p = 0.022).Furthermore, significant differences in IL-β1 and TNF-α mRNA expression between patients and controls were demonstrated. This is a starting study to understand the multiple factors involved in the onset and in the progression of ALS, with particular attention given on inflammatory genes. *Corresponding author: Mariaclara Cuccia, Head of Immunogenetics laboratory, Department of Biology and Biotechnology, University of Pavia, Via Ferrata 1, 27100 Pavia, Italy, Tel: (39)0382-985529; Fax: (39)0382-528496; E-mail: mariaclara.cuccia@ unipv.it Received Date: September 29, 2015 Accepted Date: January 12, 2016 Published Date: January 19, 2016 Citation: Cuccia, M., et al. Risk Profile for Amyotrophic Lateral Sclerosis (ALS): An Approach with the Study on Cytokine Polymorphisms. (2016) Int J Neurol Brain Disord 3(1): 1-3. Int J Neurol Brain Disord | Volume 3: Issue 1 www.ommegaonline.org

[1]  Stephen A. Goutman,et al.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era , 2015, Nature Reviews Neurology.

[2]  S. Appel,et al.  Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis , 2013, Journal of Neuroimmune Pharmacology.

[3]  I. Evdokimidis,et al.  Alterations of T cell subsets in ALS: a systemic immune activation? , 2012, Acta neurologica Scandinavica.

[4]  S. Appel,et al.  Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice , 2011, Brain, Behavior, and Immunity.

[5]  P. Mccombe,et al.  The Role of Immune and Inflammatory Mechanisms in ALS , 2011, Current molecular medicine.

[6]  U. Laforenza,et al.  SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis , 2010, Neurobiology of Disease.

[7]  P. Shaw,et al.  Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. , 2010, Free radical biology & medicine.

[8]  S. Hewett,et al.  Interleukin‐1β: a bridge between inflammation and excitotoxicity? , 2008 .

[9]  R. Bowser,et al.  Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis , 2007, Proceedings of the National Academy of Sciences.

[10]  N. Brabers,et al.  Role of the pro‐inflammatory cytokines TNF‐α and IL‐1β in HIV‐associated dementia , 2006, European journal of clinical investigation.

[11]  G. Mazzini,et al.  Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients , 2006, Neuroscience Letters.

[12]  M. Hollegaard,et al.  Cytokine gene polymorphism in human disease: on-line databases, Supplement 3 , 2006, Genes and Immunity.

[13]  I. Rahman,et al.  Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF‐κB activation and proinflammatory cytokine release in alveolar epithelial cells , 2004 .

[14]  D. Riediger,et al.  Analysis of polymorphic TGFB1 codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults , 2004, BMC Medical Genetics.

[15]  S. Rendine,et al.  Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[16]  Z. Stelmasiak,et al.  Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. , 2002, Cytokine.

[17]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases, Supplement 2 , 2002, Genes and Immunity.

[18]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[19]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.

[20]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Arveiler,et al.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.

[22]  I. Rahman,et al.  Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.